Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Katherine Ross

Physician Assistant Little Rock, AR Physician Assistant

NPI 1861077109 CMS profile 10897885

11400 Huron Ln, Little Rock, AR 72211

Open in the dashboard

General payments

$44,231

420 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Katherine Ross of Little Rock, AR is reported in the CMS Open Payments database as having received $44,231 across 420 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,094 83
2024 General $16,586 115
2023 General $7,004 107
2022 General $1,963 83
2021 General $584 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Katherine Ross
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Katherine Ross were reported at $18,094. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Katherine Ross Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $584 $132 $37–$438 $132
2022 $1,963 $155 $48–$522 $149
2023 $7,004 $167 $52–$557 $160
2024 $16,586 $178 $55–$600 $164
2025 $18,094 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Sanofi-Aventis U.S. LLC $36,022 57 payments
  2. Medtronic, Inc. $1,470 27 payments
  3. Corcept Therapeutics $899 34 payments
  4. Dexcom, Inc. $789 58 payments
  5. Xeris Pharmaceuticals, Inc. $710 34 payments
  6. Novo Nordisk Inc $677 26 payments
  7. Lilly USA, LLC $638 35 payments
  8. Abbott Laboratories $538 27 payments
  9. AbbVie, Inc. $401 21 payments
  10. Bayer HealthCare Pharmaceuticals Inc. $287 14 payments
  11. Other $1,800 87 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,257 26 payments
  2. Food and Beverage $8,598 377 payments
  3. Travel and Lodging $7,300 14 payments
  4. Education $76 3 payments
Products named General payments · program years 2021–2025
  1. TZIELD $34,550 50 payments
  2. MINIMED 780G $909 24 payments
  3. Korlym $899 34 payments
  4. Dexcom G6 Transmitter $638 54 payments
  5. MINIMED 770G $550 2 payments
  6. RECORLEV $448 19 payments
  7. FreeStyle Libre 3 $447 26 payments
  8. Kerendia $287 14 payments
  9. SYNTHROID $285 16 payments
  10. Wegovy $272 6 payments
  11. Other $3,798 192 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

420 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record